Article Details

Xenon Pharmaceuticals (NASDAQ:XENE) Raised to Hold at Zacks Investment Research

Retrieved on: 2021-03-05 12:50:11

Tags for this article:

Click the tags to see associated articles and topics

Xenon Pharmaceuticals (NASDAQ:XENE) Raised to Hold at Zacks Investment Research. View article details on hiswai:

Excerpt

Acadian Asset Management LLC now owns 82,717 shares of the biopharmaceutical company's stock valued at $915,000 after acquiring an additional ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up